New York Times Business⚪ Neutral📖 1 min read · 36 words
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
Bearish
Neutral(50% confidence)
BullishModerna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.